These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 7515911)
1. Molecular context of a viral T cell determinant within a chimeric bacterial protein alters the diversity of its T cell recognition. Lo-Man R; Martineau P; Betton JM; Hofnung M; Leclerc C J Immunol; 1994 Jun; 152(12):5660-9. PubMed ID: 7515911 [TBL] [Abstract][Full Text] [Related]
2. Overcoming the crypticity of a viral T cell determinant by insertion into a chimeric bacterial protein. Lo-Man R; Martineau P; Manoury-Schwartz B; Hofnung M; Leclerc C Int Immunol; 1996 Aug; 8(8):1245-55. PubMed ID: 8918694 [TBL] [Abstract][Full Text] [Related]
3. The cellular location of a foreign B cell epitope expressed by recombinant bacteria determines its T cell-independent or T cell-dependent characteristics. Leclerc C; Charbit A; Martineau P; Deriaud E; Hofnung M J Immunol; 1991 Nov; 147(10):3545-52. PubMed ID: 1719080 [TBL] [Abstract][Full Text] [Related]
4. Induction of T cell responses by chimeric bacterial proteins expressing several copies of a viral T cell epitope. Lo-Man R; Martineau P; Hofnung M; Leclerc C Eur J Immunol; 1993 Nov; 23(11):2998-3002. PubMed ID: 8223877 [TBL] [Abstract][Full Text] [Related]
5. Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes. Martineau P; Guillet JG; Leclerc C; Hofnung M Gene; 1992 Apr; 113(1):35-46. PubMed ID: 1373395 [TBL] [Abstract][Full Text] [Related]
6. Modulating the immunological properties of a linear B-cell epitope by insertion into permissive sites of the MalE protein. Martineau P; Leclerc C; Hofnung M Mol Immunol; 1996 Dec; 33(17-18):1345-58. PubMed ID: 9171894 [TBL] [Abstract][Full Text] [Related]
7. Immunodominance of a recombinant T-cell epitope depends on its molecular environment. Leclerc C; Martineau P; Charbit A; Lo-Man R; Dériaud E; Hofnung M Mol Immunol; 1993 Dec; 30(17):1561-72. PubMed ID: 8247026 [TBL] [Abstract][Full Text] [Related]
8. Induction of virus-neutralizing antibodies by bacteria expressing the C3 poliovirus epitope in the periplasm. The route of immunization influences the isotypic distribution and the biologic activity of the antipoliovirus antibodies. LeClerc C; Martineau P; Van der Werf S; Deriaud E; Duplay P; Hofnung M J Immunol; 1990 Apr; 144(8):3174-82. PubMed ID: 2157762 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of viral B- and T-cell epitopes expressed in recombinant bacterial proteins. Leclerc C; Lo-Man R; Charbit A; Martineau P; Clément JM; Hofnung M Int Rev Immunol; 1994; 11(2):123-32. PubMed ID: 7519229 [TBL] [Abstract][Full Text] [Related]
10. Crystallization of genetically engineered active maltose-binding proteins, including an immunogenic viral epitope insertion. Rodseth LE; Martineau P; Duplay P; Hofnung M; Quiocho FA J Mol Biol; 1990 Jun; 213(4):607-11. PubMed ID: 1694248 [TBL] [Abstract][Full Text] [Related]
11. Homogeneous processing and presentation of a recombined T cell epitope in inbred mice of different non-MHC genetic background. Lo-Man R; Martineau P; Hofnung M; Leclerc C Cell Immunol; 1996 Sep; 172(2):180-91. PubMed ID: 8964079 [TBL] [Abstract][Full Text] [Related]
12. Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein. Coëffier E; Clément JM; Cussac V; Khodaei-Boorane N; Jehanno M; Rojas M; Dridi A; Latour M; El Habib R; Barré-Sinoussi F; Hofnung M; Leclerc C Vaccine; 2000 Nov; 19(7-8):684-93. PubMed ID: 11115689 [TBL] [Abstract][Full Text] [Related]
14. Revealing the in vivo behavior of CD4+ T cells specific for an antigen expressed in Escherichia coli. Chen ZM; Jenkins MK J Immunol; 1998 Apr; 160(7):3462-70. PubMed ID: 9531307 [TBL] [Abstract][Full Text] [Related]
15. Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aroA strain of Salmonella typhimurium upon genetic coupling to two Escherichia coli carrier proteins. Charbit A; Martineau P; Ronco J; Leclerc C; Lo-Man R; Michel V; O'Callaghan D; Hofnung M Vaccine; 1993 Sep; 11(12):1221-8. PubMed ID: 8256503 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of viral B-cell epitopes inserted into two surface loops of the Escherichia coli K12 LamB protein and expressed in an attenuated aroA strain of Salmonella typhimurium. Wang J; Michel V; Leclerc C; Hofnung M; Charbit A Vaccine; 1999 Jan; 17(1):1-12. PubMed ID: 10078601 [TBL] [Abstract][Full Text] [Related]
17. Expression and immune response to foreign epitopes in bacteria. Perspectives for live vaccine development. Charbit A; Newton SM; Klebba PE; Clément JM; Fayolle C; Lo-Man R; Leclerc C; Hofnung M Behring Inst Mitt; 1997 Feb; (98):135-42. PubMed ID: 9382734 [TBL] [Abstract][Full Text] [Related]
18. High level expression of hepatitis B virus preS1 peptide in Escherichia coli. Rhyum SB; Jin BR; Park HR; Hong HJ J Biotechnol; 1994 Aug; 36(3):221-30. PubMed ID: 7765264 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of poliovirus B and T cell epitopes presented by hybrid porcine parvovirus particles. Sedlik C; Sarraseca J; Rueda P; Leclerc C; Casal I J Gen Virol; 1995 Sep; 76 ( Pt 9)():2361-8. PubMed ID: 7561778 [TBL] [Abstract][Full Text] [Related]
20. Preserved epitope-specific T cell activation by recombinant Bet v 1-MBP fusion proteins. van Neerven RJ; Sparholt SH; Schou C; Larsen JN Clin Exp Allergy; 1998 Apr; 28(4):423-33. PubMed ID: 9641568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]